3 RESULTS
The average age of all the 100 male patients evaluated was 62.37 years .
All of the patients evaluated had undergone TUR operation due to a
bladder tumor in the clinic of the current study. Any statistical
difference in age between the groups was not indicated .
The mean number of cystoscopies performed for control purposes was 8,
7.4, 8.6, 6.45, 7.05 and in the 25-mg lidocaine, 4-mL levobupivacaine,
6-mL levobupivacaine, 8-mL levobupivacaine, and 10-mL levobupivacaine
groups, respectively. The number of cystoscopies in the 6-mL
levobupivacaine group was found to be significant compared with the 8-mL
levobupivacaine group . No significant difference exists in the number
of cystoscopies among other groups .
On the one hand, the lowest VAS score during the cystoscopy procedure
was 1 , the highest was 5, and the average was 3.6. In the 6-mL
levobupivacaine group, 2, 4, and 2.75 were the lowest, highest, and
average, respectively. Moreover, in the 8-mL levobupivacaine group, 2,
3, and 2.4 were the lowest, highest, and average, respectively. In the
10-mL levobupivacaine group, 1, 3, and 2.00 were the lowest, highest,
and mean, respectively. On the other hand, in the 25-mg lidocaine group,
the lowest, highest, and average VAS scores were 4, 8, and 5.55,
respectively. The VAS score of the 25-mg lidocaine group during the
procedure was significantly higher . Moreover, the VAS scores decreased
as the dose increased when the levobupivacaine groups were evaluated by
titration. The score of the 4-mL levobupivacaine group during the
procedure was significantly higher than the other levobupivacaine groups
. No significant difference exists between the other groups in the score
during the procedure .
The lowest, highest, and average VAS scores after the cystoscopy
procedure were 1, 3, and 2.20, in the 4-mL levobupivacaine group,
respectively. However, the lowest, highest, and average VAS scores were
1, 3, and 1.80 in the 6-mL levobupivacaine group, respectively. In
addition, the lowest, highest, and average VAS scores were 1, 2, and
1.45 in the 8-mL levobupivacaine group, respectively. The lowest,
highest, and average VAS scores were 1, 2, and 1.15 in the 10-mL
levobupivacaine group, respectively. The lowest, highest, and average
post procedure VAS scores in the 25-mg lidocaine group were 2, 5, and
3.35, respectively. In addition, the post procedure VAS scores of the
25-mg lidocaine and 4-mL levobupivacaine groups were significantly
higher than the other groups . The post procedure score of the 6-mL
levobupivacaine group was significantly higher than the 10-mL
levobupivacaine group . Any significant difference was not detected in
the postprocedure score among the other groups .
Patient satisfaction in this study was 70% in the 4-, 6-, and 8-mL
levobupivacaine groups. However, it was 95% in the 10-mL
levobupivacaine group. No significant difference in satisfaction values
among other groups was found . Moreover, patient satisfaction was 30%
in the 25-mg lidocaine group, which was significantly lower than the
other groups .